Cipher Pharmaceuticals Stock
Cipher Pharmaceuticals Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Craig J. Mull
- Employees
- 5
- Market cap
- $337 M
- IPO
- 07/05/2004
Cipher Pharmaceuticals Inc., founded in 2000 and based in Oakville, Canada, operates as a specialized pharmaceutical enterprise. The company markets a diverse portfolio of commercial therapeutic solutions. These include Epuris (CIP-ISOTRETINOIN), formulated for severe acne; Ozenoxacin, targeting impetigo in both adult…
Cipher Pharmaceuticals stock: price history
1D
-2.1%
1W
-2.9%
1M
-8.7%
6M
-27.4%
YTD
-12.0%
1Y
-10.0%
2Y
-22.1%
5Y
+434.3%
10Y
+172.1%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~14% stronger price swings than usual
Ask the agents about Cipher Pharmaceuticals
Analyst assessment of Cipher Pharmaceuticals
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 01/06/2023
Cipher Pharmaceuticals stock metrics
P/E
8.22
P/B
1.74
EV/EBITDA
9.38
RETURN ON EQUITY
2.9%
NET MARGIN
33.3%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
56.8%
FLOAT SHARES
14,446,553
AVG. DAILY VOLUME (30D)
22,057
Comparable stocks
Frequently asked questions about Cipher Pharmaceuticals stock
What does Cipher Pharmaceuticals do?
Cipher Pharmaceuticals Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Craig J. Mull, the company employs around 5 people.
The IPO was on 07/05/2004; the stock trades on TSX under the ticker CPH.TO.
What do analysts say about Cipher Pharmaceuticals stock?
1 analysts rate the stock, the consensus is Buy (as of 01/06/2023).
This is an external assessment, not a statement by Market Jury.
When does Cipher Pharmaceuticals report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 14% stronger than usual.
Does Cipher Pharmaceuticals pay a dividend?
No, Cipher Pharmaceuticals currently does not pay a dividend.
Which stocks are comparable to Cipher Pharmaceuticals?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Cipher Pharmaceuticals stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cipher Pharmaceuticals against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.